| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | ||
| 1.502.245.473 $ | -528.694.793 $ | 2.048.436.266 $ | +631.716.970 $ | 1.416.719.296 $ | +59.635.450 $ | 1.357.083.846 $ | +1.357.083.846 $ | ||
| BANK OF AMERICA CORP /DE/ | BAC | 1.388.285.473 $ | -458.597.293 $ | 1.846.882.766 $ | +532.573.787 $ | 1.314.308.979 $ | +81.163.405 $ | 1.233.145.574 $ | +1.233.145.574 $ |
| SOLENO THERAPEUTICS INC | SLNO | 55.560.000 $ | -35.700.000 $ | 91.260.000 $ | +40.154.200 $ | 51.105.800 $ | -31.061.700 $ | 82.167.500 $ | +82.167.500 $ |
| Centessa Pharmaceuticals plc | CNTA | 25.010.000 $ | -44.102.500 $ | 69.112.500 $ | +25.772.983 $ | 43.339.517 $ | +9.293.745 $ | 34.045.772 $ | +34.045.772 $ |
| LB PHARMACEUTICALS INC | LBRX | 33.390.000 $ | +9.705.000 $ | 23.685.000 $ | +23.685.000 $ | ||||
| ENANTA PHARMACEUTICALS INC | ENTA | 9.576.000 $ | +9.576.000 $ | ||||||
| MORGAN STANLEY | MS | 7.920.000 $ | -45.000 $ | 7.965.000 $ | +240.000 $ | 7.725.000 $ | +7.725.000 $ | ||
| 1.502.245.473 $ | -528.694.793 $ | 2.048.436.266 $ | +631.716.970 $ | 1.416.719.296 $ | +59.635.450 $ | 1.357.083.846 $ | +1.357.083.846 $ | ||
Erweiterte Einstellungen
×